Quantum computational investigations and molecular docking studies on amentoflavone

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Parasitology

Background:

• Chagas disease, caused by Trypanosoma cruzi, is a neglected tropical disease with limited treatment options.
• Existing drugs for Chagas disease have low efficacy, necessitating the development of novel therapeutic agents.
• Amentoflavone, a biflavonoid, exhibits in vitro anti-trypanosomal activity, making it a candidate for drug development.

Purpose of the Study:

• To investigate the potential of amentoflavone as an antichagasic pharmacological tool.
• To computationally assess the reactivity and interaction profile of amentoflavone with cruzain, a crucial enzyme in T. cruzi.

Main Methods:

• Density Functional Theory (DFT) calculations were employed to determine reactivity descriptors and structural properties of amentoflavone.
• Infrared spectrum, frontier orbitals (HOMO-LUMO), Fukui analysis, and thermodynamic properties were calculated.
• Molecular docking studies were performed to analyze the interaction between amentoflavone and the target enzyme, cruzain.

Main Results:

• DFT calculations provided insights into the chemical behavior and reactivity of amentoflavone.
• Molecular docking revealed significant interactions between amentoflavone and amino acid residues in the catalytic sites of cruzain.
• These interactions suggest amentoflavone's potential to inhibit cruzain's enzymatic activity.

Conclusions:

• Amentoflavone demonstrates potential as a pharmacological agent against Chagas disease.
• The compound's ability to interact with cruzain indicates its promise as a lead compound for developing new antichagasic drugs.
• Further research is warranted to explore amentoflavone's therapeutic efficacy and safety.